
Robin Röhm
Co-founder and CEO, Apheris
Co-founder and CEO, Apheris
February 10, 2023
AI for drug discovery has enormous potential; to unlock it, we need to reset our mindset
5 min read
Receive the latest analytical science news, personalities, education, and career development – weekly to your inbox.
False
False